Opposition proceedings before the European Patent Office are at the heart of Uexküll & Stolberg's practice, which counts a number of large global corporations, often from the chemical, pharmaceutical and biotechnology sectors among its client base; the latter area represents a central expertise for Albrecht von Menges. Bernd Christian Janssen regularly advises on matters relating to chemistry and, alongside dispute resolution, also handles prosecution issues.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Amgen Inc.
- ExxonMobil
- Monsanto/Bayer
- Janssen Pharmaceutical
- Johnson&Johnson
- Ivoclar
- Bristol-Myers-Squibb / Pfizer
- KRKA
- Medac
- Sealed Air
Highlight-Mandate
- Representation of the Bristol-Myers-Squibb/Pfizer alliance in several opposition proceedings before the European Patent Office (EPO) against up to 11 opponents.
- Representing Amgen in opposition proceedings before the EPO against patent EP 3 230 316 of Bayer HealthCare LLC.
- Representing ExxonMobil in opposition proceedings before the EPO against patent EP 3 652376 relating to a backing composition for carpets.
Anwält*innen
Praxisleitung
Bernd Christian Janssen; Albrecht von Menges